BR112019005025A2 - sistema e método para caracterizar um painel - Google Patents

sistema e método para caracterizar um painel

Info

Publication number
BR112019005025A2
BR112019005025A2 BR112019005025A BR112019005025A BR112019005025A2 BR 112019005025 A2 BR112019005025 A2 BR 112019005025A2 BR 112019005025 A BR112019005025 A BR 112019005025A BR 112019005025 A BR112019005025 A BR 112019005025A BR 112019005025 A2 BR112019005025 A2 BR 112019005025A2
Authority
BR
Brazil
Prior art keywords
panel
user
resources
operable
microbiome
Prior art date
Application number
BR112019005025A
Other languages
English (en)
Other versions
BR112019005025A8 (pt
Inventor
Goddard Audrey
Almonacid Daniel
Bik Elisabeth
Ossandon Francisco
Richman Jessica
Pablo Cardenas Juan
Kraal Laurens
Apte Zachary
Original Assignee
Ubiome Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US15/606,743 external-priority patent/US10803991B2/en
Application filed by Ubiome Inc filed Critical Ubiome Inc
Publication of BR112019005025A2 publication Critical patent/BR112019005025A2/pt
Publication of BR112019005025A8 publication Critical patent/BR112019005025A8/pt

Links

Classifications

    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B30/00—ICT specially adapted for sequence analysis involving nucleotides or amino acids
    • G16B30/10—Sequence alignment; Homology search
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B1/00—Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B25/00—ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
    • G16B25/10—Gene or protein expression profiling; Expression-ratio estimation or normalisation
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
    • G16B40/10—Signal processing, e.g. from mass spectrometry [MS] or from PCR
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B50/00—ICT programming tools or database systems specially adapted for bioinformatics
    • G16B50/30—Data warehousing; Computing architectures
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/30—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A90/00—Technologies having an indirect contribution to adaptation to climate change
    • Y02A90/10—Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physics & Mathematics (AREA)
  • Medical Informatics (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Theoretical Computer Science (AREA)
  • Pathology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Evolutionary Biology (AREA)
  • Databases & Information Systems (AREA)
  • Epidemiology (AREA)
  • Data Mining & Analysis (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Primary Health Care (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Surgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Obesity (AREA)

Abstract

trata-se de um sistema e método para caracterizar um painel de afecções associadas a um conjunto de táxons em relação a micro-organismos que podem incluir um banco de dados taxonômicos incluindo recursos de microbioma de referência para o conjunto de táxons associado ao painel de afecções; uma manipulação operável para coletar um recipiente incluindo material biológico a partir de um usuário, em que o sistema de manipulação compreende um sistema sequenciador operável para determinar um conjunto de dados de sequência de micro-organismos; e um sistema de caracterização de painel operável para: determinar recursos de microbioma de usuário para o conjunto de táxons para o usuário com base no conjunto de dados de sequência de micro-organismos, gerar uma comparação entre os recursos de microbioma de usuário e os recursos de microbioma de referência, e determinar uma caracterização de painel para o painel de condições para o usuário com base na comparação; e um sistema de tratamento operável para promover uma terapia para uma condição do painel de condições com base no caracterização de painel.
BR112019005025A 2016-09-16 2017-09-18 Sistema e método para caracterizar um painel BR112019005025A8 (pt)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201662395939P 2016-09-16 2016-09-16
US15/606,743 US10803991B2 (en) 2014-10-21 2017-05-26 Method and system for microbiome-derived diagnostics and therapeutics
US201762520058P 2017-06-15 2017-06-15
US201762525379P 2017-06-27 2017-06-27
PCT/US2017/052098 WO2018053443A1 (en) 2016-09-16 2017-09-18 Method and system for panel characterizations

Publications (2)

Publication Number Publication Date
BR112019005025A2 true BR112019005025A2 (pt) 2019-06-18
BR112019005025A8 BR112019005025A8 (pt) 2023-03-21

Family

ID=61619786

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112019005025A BR112019005025A8 (pt) 2016-09-16 2017-09-18 Sistema e método para caracterizar um painel

Country Status (11)

Country Link
EP (1) EP3512421A4 (pt)
JP (1) JP7114091B2 (pt)
KR (1) KR102486181B1 (pt)
CN (1) CN109715059A (pt)
AU (1) AU2017326564A1 (pt)
BR (1) BR112019005025A8 (pt)
CA (1) CA3036994A1 (pt)
CO (1) CO2019003713A2 (pt)
SG (1) SG11201901726QA (pt)
WO (1) WO2018053443A1 (pt)
ZA (1) ZA201901371B (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109943636B (zh) * 2019-04-11 2020-01-24 上海宝藤生物医药科技股份有限公司 一种结直肠癌微生物标志物及其应用
CN110669818B (zh) * 2019-10-30 2021-08-24 中南大学 多发性骨髓瘤肠道微生物标志物及应用和检测制剂
KR102373889B1 (ko) * 2020-01-23 2022-03-15 주식회사 에이치이엠파마 장내 환경 개선을 위한 맞춤형 솔루션을 제공하는 방법 및 서버
WO2022160358A1 (zh) * 2021-02-01 2022-08-04 苏州大学附属儿童医院 肠道微生物作为早产儿支气管肺发育不良症标志物的应用
KR102304402B1 (ko) * 2021-03-26 2021-09-24 주식회사 에이치이엠파마 머신러닝 모델을 이용하여 비만 여부를 판별하는 방법 및 진단 장치
CN118020106A (zh) 2021-09-29 2024-05-10 富士胶片株式会社 可测定合适特征量的选择方法、可测定合适特征量的选择程序及可测定合适特征量的选择装置

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9848760B2 (en) * 2009-06-29 2017-12-26 Gearbox, Llc Devices for continual monitoring and introduction of gastrointestinal microbes
CN105407728A (zh) * 2013-07-21 2016-03-16 霍勒拜欧姆公司 用于微生物组表征、监测和治疗的方法和系统
EP2876167A1 (en) * 2013-11-21 2015-05-27 Institut Gustave Roussy Microbiota composition, as a marker of responsiveness to chemotherapy, and use of microbial modulators (pre-,pro- or synbiotics) for improving the efficacy of a cancer treatment
US9663831B2 (en) * 2014-01-25 2017-05-30 uBiome, Inc. Method and system for microbiome analysis
AU2015335907A1 (en) * 2014-10-21 2017-04-13 Psomagen, Inc. Method and system for microbiome-derived diagnostics and therapeutics
EP3283085A4 (en) * 2015-04-13 2019-04-10 Ubiome, Inc. METHOD AND SYSTEM FOR MICROBIBLE DERIVED DIAGNOSIS AND THERAPEUTIC FOR DISEASES RELATED TO TAXONOMIC MICROBIAL MATERIALS

Also Published As

Publication number Publication date
CN109715059A (zh) 2019-05-03
SG11201901726QA (en) 2019-03-28
EP3512421A4 (en) 2021-08-11
CA3036994A1 (en) 2018-03-22
BR112019005025A8 (pt) 2023-03-21
JP7114091B2 (ja) 2022-08-08
EP3512421A1 (en) 2019-07-24
CO2019003713A2 (es) 2019-04-30
AU2017326564A1 (en) 2019-03-28
KR20190055127A (ko) 2019-05-22
ZA201901371B (en) 2019-11-27
KR102486181B1 (ko) 2023-01-06
JP2019528729A (ja) 2019-10-17
WO2018053443A1 (en) 2018-03-22

Similar Documents

Publication Publication Date Title
BR112019005025A2 (pt) sistema e método para caracterizar um painel
MX2016016902A (es) Metodos para analizar acidos nucleicos de celulas individuales o poblaciones de celulas.
MY192493A (en) Urinalysis device and dry reagent for quantitative urinalysis
MY190947A (en) Fluid control
BR112019000709A8 (pt) Sistema para avaliar uma condição tratável com antibióticos em relação a um usuário e método para avaliar uma condição associada a antibióticos em relação a um primeiro usuário
BR112017006088A2 (pt) uso de painéis de genes fgfr mutantes na identificação de pacientes com câncer que serão responsivos ao tratamento com um inibidor de fgfr
MX2020010947A (es) Metodos de tratamiento de enfermedad de alzheimer.
WO2015112352A3 (en) Method and system for microbiome analysis
PH12017501967A1 (en) Maize plant dbn9936 and method for use in detecting nucleic acid sequence thereof
BR112016017155A2 (pt) Sistema e dispositivo para geração com alto rendimento de gotículas combinatoriais e métodos de uso
BR112017009151A2 (pt) ensaios para detectar subgrupos imunológicos de célula t e métodos de uso dos mesmos
BR112019005810A2 (pt) método para sequenciamento de microbioma melhorado para caracterizar uma afecção relacionada a micro-organismo para um usuário associado a uma amostra biológica, e método para sequenciamento de microbioma melhorado
BR112018006393A2 (pt) método para classificar um linfoma difuso de grande célula b (dlbcl), uma ou mais mídias de armazenamento legíveis por computador, sistema de computação adaptado e kit
AU2016250096A8 (en) Method and system for microbiome-derived characterization, diagnostics and therapeutics for conditions associated with functional features
BR112021009441A2 (pt) Multiplexação de variantes virais de alta evolução com sherlock
Nababan et al. The Effect Of Giving Ocimum sanctum L. Leaf Extract On Growth Of Bacteria Bacillus cereus
PT115216A (pt) Método para identificar microrganismos patogénicos e marcadores de resistência usando análise de fragmentos de pcr multiplex
BR112022010472A2 (pt) Método de previsão de requisitos para terapia biológica
ZUHRI EVALUATION THE LECTURER PERFORMANCE (BE REVIEWED FROM CERTIFICATION AND WORK EXPERIENCE IN STATE INSTITUTE FOR ISLAMIC STUDIES SULTHAN THAHA SAIFUDDIN JAMBI)
Chilingarian et al. VizieR Online Data Catalog: Isolated compact elliptical galaxies (Chilingarian+, 2015)
Okere Construct validity, responsiveness, and demographic predictors of the inventory for assessing the process of cultural competence among healthcare professionals-student version (IAPCC-SV©)
UA110998U (uk) Спосіб діагностики розвитку остеопорозу
Cheeseboro et al. A WISE Selection of MIR AGN in Different Environments
Permadi Pengaruh Gaya Kepemimpinan Terhadap Kinerja Karyawan Pada Kantor Jasa Penilai Publik (KJPP) Sih Wiryadi dan Rekan area Samarinda
Tsyrenova et al. The development of human culture of students by means of mathematics

Legal Events

Date Code Title Description
B350 Update of information on the portal [chapter 15.35 patent gazette]
B06W Patent application suspended after preliminary examination (for patents with searches from other patent authorities) chapter 6.23 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: AS CLASSIFICACOES ANTERIORES ERAM: A61B 5/05 , A61B 1/00 , G06F 19/00

Ipc: A61B 5/05 (2021.01), G16H 50/20 (2018.01)

B11B Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements